Correlation Between Urine UACR and Postoperative Neurocognitive Disorder in Elderly Patients With Non-cardiac Surgery

NCT ID: NCT03860714

Last Updated: 2019-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-01

Study Completion Date

2020-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study intends to evaluate the relationship between urinary albumin/creatinine ratio and postoperative neurocognitive impairment in elderly non-cardiac surgery patients. The results of the study are to identify risk factors, screen high-risk populations to improve clinical evidence, early detection and early treatment.And reducing the burden of PNCD on patients and their families, hospitals and public resources.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Cognitive Dysfunction Delirium

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

study group

400 Male and female patients undergoing non-cardiac surgery at the Affiliated Hospital of Xuzhou Medical University \[Jiangsu China\].We do the neuropsychological tests,MMSE,CCI,CDR,QoR-40,GDS,CAGE Alcoholism Questionnaire,Pure Tone Audiometry,blood albumin、hemoglobin content、ALT、AST、BUN、Cr、serum folic acid、vitamin B12、homocysteine and branched chain amino acid content 1 day before the surgery(baseline); 1 day before the surgery(baseline); Confusion Assessment Method(CAM),NRS once before discharge from PACU and 1、2、3 days after surgery twice a day; QoR-40 1 day after surgery; Neuropsychological tests and MMSE 6±1 days and one month after surgery.

Neuropsychological tests

Intervention Type DIAGNOSTIC_TEST

We do the neuropsychological tests, Mini-Mental score examination (MMSE),Charlson Comorbidity Index(CCI),Clinical Dementia Rating(CDR),Quality of Recovery Score - 40 (QoR-40),Geriatric Depression Scale (GDS),CAGE Alcoholism Questionnaire,Pure Tone Audiometry,blood albumin、hemoglobin content、ALT、AST、BUN、Cr、serum folic acid、vitamin B12、homocysteine and branched chain amino acid content 1 day before the surgery(baseline); 1 day before the surgery(baseline); Confusion Assessment Method(CAM),Numerical Rating Scale(NRS)once before discharge from PACU and 1、2、3 days after surgery twice a day; QoR-40 1 day after surgery; Neuropsychological tests and MMSE 6±1 days and one month after surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neuropsychological tests

We do the neuropsychological tests, Mini-Mental score examination (MMSE),Charlson Comorbidity Index(CCI),Clinical Dementia Rating(CDR),Quality of Recovery Score - 40 (QoR-40),Geriatric Depression Scale (GDS),CAGE Alcoholism Questionnaire,Pure Tone Audiometry,blood albumin、hemoglobin content、ALT、AST、BUN、Cr、serum folic acid、vitamin B12、homocysteine and branched chain amino acid content 1 day before the surgery(baseline); 1 day before the surgery(baseline); Confusion Assessment Method(CAM),Numerical Rating Scale(NRS)once before discharge from PACU and 1、2、3 days after surgery twice a day; QoR-40 1 day after surgery; Neuropsychological tests and MMSE 6±1 days and one month after surgery.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Non-cardiac surgery patients;

* Age is greater than or equal to 60 years old; ③Han Nationality, mother tongue is chinese;

④The MMSE score:Illiteracy is greater than or equal to 17 points, primary school is greater than or equal to 20 points, higher secondary school is more than 24 points;

⑤The people signed informed consent.

Exclusion Criteria

* The diagnosis of preoperative delirium;

* The diagnosis Unstable hypertension(Such as:pheochromocytoma or aortic dissection); ③Severe chronic obstructive pulmonary disease or congestive heart failure; ④Severe liver and kidney dysfunction;
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Han Yuan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Han Yuan

Doctor-in-charge of Anesthetist

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Anesthesia of the Affiliated Hospital of Xuzhou Medical University

Xuzhou, Jiangsu, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Junli Cao

Role: CONTACT

+86 15162160809

Yuan Han

Role: CONTACT

+86 13852470693

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Cao Junli

Role: primary

+86 15162160809

Han Yuan

Role: backup

+86 13852470693

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

XYFY2019-KL015-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.